Joshua Fitch, Senior Editor

How providers can advocate for increased research determining social media and its association with youth mental health.

The decision makes pitolisant the first and only FDA-approved, non-scheduled treatment option for daytime sleepiness in this patient population.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

For ambulatory Duchenne patients, delandistrogene moxeparvovec-rokl was granted traditional approval, while accelerated approval was granted for non-ambulatory patients.

The disparity among specialist care for children with Medicaid vs private insurance was further widened for children with persistent asthma.

Participants included adolescents aged 13 to 17 years with severe obesity, defined as at or greater than 120% of the 95th BMI percentile.

Brief but practical reminders to help prevent drowning in children from the perspective of an emergency medicine fellow.

A discussion and explanation of metatarsus adductus, why screening is important, and the UNFO brace for treatment.

Findings "suggest that LUS is a promising tool for estimating respiratory outcomes in the first 2 years of life," wrote the study investigators.

The company also announced that it has surpassed its interim analysis enrollment target and expects topline phase 3 data from the FORTIFY study (NCT05775848) among individuals with LGMD21/R9 in 2025.

The USPSTF is encouraging providers to promote behavioral interventions as the primary effective intervention for weight loss in children and adolescents.

The national survey revealed parents are eager to learn more about school-based mental health services.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Water safety tips from the CDC including drowning prevention, pool chemical injury prevention, and keeping swimmers safe.

Experts highlight common waterborne illnesses, preventive tips for summer.

The decision is based on statistical significance achieved in the T2NOW trial, which demonstrated reduction of A1C.

Unexpected seasonal RSV following COVID-19 highlighted the need for ongoing research to better understand transmission and ongoing impact from the pandemic.

The primary outcome was an elevated HbA1c level greater than or equal to 5.7% (prediabetes or undiagnosed presumed T2D).

pJIA can lead to an increased risk of permanent joint damage as well as delayed growth and development.

Overall, the findings of the study support the clinical utility of combining trio-WES sequencing with CNV-seq in the etiologic diagnosis and management of early-childhood GDD.

Once-daily, steroid-free, topical roflumilast cream 0.15% has a PDUFA date of July 7, 2024.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The 2-drug, fixed-dose combination tablet contains darunavir, an HIV-1 protease inhibitor, and cobicistat, a CYP3A inhibitor that serves as a PK enhancer or “booster.”

Over the winter, the omicron JN.1 lineages overtook XBB strains as dominant.

Though some drowning prevention strategies seem common or routine, data demonstrate drowning deaths among children have risen in recent years, which should prompt conversations with families on refreshers and new prevention initiatives.

Additionally, a new weight-based oral solution, RINVOQ LQ, is now available as an option for the pediatric populations.

Management of ICEP with monoclonal antibodies against IL-5 and IgE (omalizumab) could be promising according to study authors, though extent of evidence is lacking.

Mesoblast Limited's chief executive announced a BLA resubmission for remestemcel-L is expected to be filed with the FDA this quarter.

The maximum daily dose has increased from 80 mg to 100 mg.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.